Ewing's
Showing 51 - 75 of 557
Late Effects, Testicular Germ Cell Tumor Mixed, Non-Metastatic Breast Carcinoma Trial in Lyon (PASCA intervention)
Recruiting
- Late Effects
- +8 more
- PASCA intervention
-
Lyon, FranceCentre Leon Berard
Mar 15, 2022
Pediatric Solid Tumor, Osteosarcoma, Rhabdomyosarcoma Trial in Memphis (Fludarabine, Cyclophosphamide, MESNA)
Recruiting
- Pediatric Solid Tumor
- +15 more
- Fludarabine
- +3 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jun 30, 2022
Ewing Sarcoma, Myxoid Liposarcoma, Sarcoma,Soft Tissue Trial in United States (Seclidemstat, Cyclophosphamide, Topotecan)
Recruiting
- Ewing Sarcoma
- +10 more
- Seclidemstat
- +2 more
-
Los Angeles, California
- +16 more
Jan 18, 2022
Ewing's Sarcoma (ES) Trial in Italy (TEMIRI, ADM, IFO)
Active, not recruiting
- Ewing's Sarcoma (ES)
- TEMIRI
- +6 more
-
Aviano, Pordenone, Italy
- +12 more
Oct 29, 2021
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Hodgkin Lymphoma Trial in Madison (TCRaß+/CD19+ depleted Haploidentical
Recruiting
- Acute Myeloid Leukemia
- +10 more
- TCRαβ+/CD19+ depleted Haploidentical HSCT
- Zoledronate
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Mar 1, 2022
Adults Treated During Childhood or Adolescence for a Malignant Bone Tumor (Osteosarcoma and Ewing Sarcoma) Trial in Villejuif
Recruiting
- Adults Treated During Childhood or Adolescence for a Malignant Bone Tumor (Osteosarcoma and Ewing Sarcoma)
- MRI
-
Villejuif, FranceGustave Roussy
Sep 27, 2021
Lymphoma, Childhood Lymphoma, Solid Tumor Trial in Charlottesville (Genistein, Placebo)
Terminated
- Lymphoma
- +15 more
- Genistein
- Placebo
-
Charlottesville, VirginiaUniversity of Virginia
Feb 8, 2022
Ewing's Sarcoma Trial in Italy (Standard treatment (as per protocol ISG SSG III), Intensified chemo)
Active, not recruiting
- Ewing's Sarcoma
- Standard treatment (as per protocol ISG SSG III)
- Intensified chemotherapy
-
Aviano, Pordenone, Italy
- +13 more
Oct 29, 2021
Pediatric Solid Tumor, Germ Cell Tumor, Retinoblastoma Trial in Seattle (second generation 4-1BB? EGFR806-EGFRt, second
Recruiting
- Pediatric Solid Tumor
- +15 more
- second generation 4-1BBζ EGFR806-EGFRt
- second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
-
Seattle, WashingtonSeattle Children's Hospital
May 2, 2022
Clear Cell Sarcoma Trial in El Segundo, Houston (AMG 337)
Terminated
- Clear Cell Sarcoma
- AMG 337
-
El Segundo, California
- +1 more
Dec 9, 2022
Relapsed Pediatric Solid Tumors, Refractory Pediatric Solid Tumors, Rhabdomyosarcoma Trial in Washington, Cincinnati (Magnetic
Active, not recruiting
- Relapsed Pediatric Solid Tumors
- +9 more
- Magnetic Resonance High Intensity Focused Ultrasound
-
Washington, District of Columbia
- +1 more
Jan 21, 2022
Recurrent or Refractory Solid Tumors, Ewing Sarcoma, Rhabdomyosarcoma Trial in United States (MM-398 (Irinotecan Sucrosofate
Recruiting
- Recurrent or Refractory Solid Tumors
- +4 more
- MM-398 (Irinotecan Sucrosofate Liposome Injection) plus cyclophosphamide
-
Cincinnati, Ohio
- +5 more
Mar 17, 2022
Bone Cancer, Bone Tumor, Solid Tumor Trial in United States (153-Sm-DOTMP (Samarium-153-DOTMP))
Recruiting
- Bone Cancer
- +4 more
- 153-Sm-DOTMP (Samarium-153-DOTMP)
-
Chicago, Illinois
- +3 more
Aug 18, 2023
Breast Cancer Female, Acute Leukemia, Lymphoma Trial in Sweden (Triptorelin Embonate, Sodium Chloride solution 0.9%)
Not yet recruiting
- Breast Cancer Female
- +5 more
- Triptorelin Embonate
- Sodium Chloride solution 0.9%
-
Göteborg, Sweden
- +16 more
Oct 26, 2022
Glioma, Neuroectodermal Tumors, Primitive, Wilms Tumor Trial in Saint Louis (Metronomic Cyclophosphamide, Thalidomide)
Recruiting
- Glioma
- +6 more
- Metronomic Cyclophosphamide
- Thalidomide
-
Saint Louis, MissouriWashington University School of Medicine
Sep 22, 2021
Ependymoma, Ewing Sarcoma, High-grade Glioma Trial in Worldwide (Nivolumab, NKTR-214)
Completed
- Ependymoma
- +9 more
- Nivolumab
- NKTR-214
-
Little Rock, Arkansas
- +17 more
Dec 8, 2022
Bone Sarcoma, Osteosarcoma, Ewing Sarcoma Trial in France (Treatment by Regorafenib, Treatment by Placebo)
Recruiting
- Bone Sarcoma
- +6 more
- Treatment by Regorafenib
- Treatment by Placebo
-
Besançon, France
- +15 more
Aug 18, 2022
Ewing Sarcoma, Rhabdomyosarcoma, Wilms Tumor Trial in Boston (Stereotactic Body Radiotherapy (SBRT))
Terminated
- Ewing Sarcoma
- +10 more
- Stereotactic Body Radiotherapy (SBRT)
-
Boston, Massachusetts
- +2 more
Apr 5, 2021
Observational Study to Assess Neuropathy in Diabetic Children
Not yet recruiting
- Diabetes Mellitus
- uroflowmetry
- +2 more
-
Budapest, HungaryHeim Pal National Pediatric Institute
Aug 3, 2022
Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma Trial in Providence (Gemcitabine, 9-ING-41,
Withdrawn
- Soft Tissue Sarcoma
- +12 more
- Gemcitabine
- +2 more
-
Providence, Rhode Island
- +1 more
Nov 30, 2021
Colorectal Carcinoma, Endometrial Carcinoma, Melanoma Trial in United States (Tegavivint)
Recruiting
- Colorectal Carcinoma
- +21 more
- Dual X-ray Absorptiometry
- +2 more
-
Birmingham, Alabama
- +18 more
Jan 30, 2023
Recurrent Alveolar Rhabdomyosarcoma, Recurrent Ewing Sarcoma, Recurrent Lymphoma Trial in United States (Elimusertib)
Recruiting
- Recurrent Alveolar Rhabdomyosarcoma
- +7 more
-
Birmingham, Alabama
- +28 more
Jan 26, 2023